Deborah Abrams Kaplan

Low prices and some gaming of regulations can drive out competitors and create monopolies that allow generic makers to jack up their prices. Experience has shown that it often takes multiple generics to achieve the promised-for downward pressure on prices.

Predictions that the company would make a major move to dominate American healthcare have not come to pass. So far.

Providers are moving toward acceptance; the rules are here to stay. Payers recognize that people need to know prices.

Governments are the only buyers so far, and the amounts they are paying varies.

Having specialty pharmacies fill prescriptions may lower costs, but critics of the practice see safety issues and other drawbacks.

William Trombatt and James Adams of AllianceRx Walgreens Prime discussed specialty pharmacy for people with MS at PBMI Specialty Rx Forum last week. The need for "higher touch" programs is important for people with MS, said Adams.

Can data mined from EHRs match that from the gold standard, randomized clinical trials?

Whether the online giant has larger healthcare ambitions is unclear.

Where some see bloat and trendiness, others see nimbleness and responsiveness.

Companies are using rewards and ‘gamification’ to encourage patients to take their pills as prescribed.

Early studies from China suggested that CT scans of the lungs could be used to diagnose the disease. But as PCR tests became available, radiology groups said CT scans should be used more sparingly and in confirmed cases.

Early detection of low blood oxygen levels may detect ‘silent hypoxia’ seen in some patients with COVID-19. But the American Lung Association advises against buying a pulse oximeter unnecessarily.

By almost any measure, these are good times for Medicare Advantage. Enrollment is growing, the number of insurers in the market is increasing, and gross margins are higher than in other health insurance markets.

Here are four programs making a difference.

There are a variety of ways, but a multi-pronged approach is best.